russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLCrussjcardiol-1803Research ArticleЛЕКЦИИLECTUREОСОБЕННОСТИ КЛИНИКИ, ДИАГНОСТИКИ И ЛЕЧЕНИЯ МИОПЕРИКАРДИТОВ И ДИФФУЗНЫХ МИОКАРДИТОВCLINIC CHARACTERISTICS, DIAGNOSTICS AND THERAPY OF MYOPERICARDITIS AND DIFFUSE MYOCARDITISМравянС. Р.MravjanS. R.ГуревичМ. А.GurevitchM. A.Московский областной научно-исследовательский клинический институт им. М.Ф. ВладимирскогоRussian Federation2003281020030599103Copyright © Мравян С.Р., Гуревич М.А., 20032003Мравян С.Р., Гуревич М.А.Mravjan S.R., Gurevitch M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/1803

В работе на основании собственного материала и литературных данных проанализировано течение вирусных миоперикардитов. Особое внимание уделено особенностям электрокардиографической динамики, выделены четыре стадии эволюции электрокардиографических признаков заболевания. Отмечено увеличение частоты геморрагических миоперикардитов, имеющих, по-видимому, вирусную природу.

Даны рекомендации по лечению больных миоперикардитом, прогноз которого позитивен. В то же время, прогноз диффузного миокардита остается неблагоприятным, а показания к его рациональному лечению - недостаточно установленными.

In study on a basement of our own research and literature data clinical course of virus myopericarditis was analyzed. Special consideration has been given to characteristics of electrocardiographic indicators, four stages of evolution of cardiographic indicators of illness were emphasized. Increase of hemorrhagic myopericarditis frequency, evidently with virus nature, was noted. Recomendations for treatment in patients suffering from myopericarditis with positive prognosis were given. At the same time, prognosis of diffuse myocarditis remains negative, and indications for its rational treatment determined insufficiently.

миокардитмиоперикардитдиагностикалечениепрогнозmyocarditismyopericarditisdiagnosticsprognosistherapyReferencesSoler-Soler J., Permanyer-Miralda G., Sagrista-Sauleda J.A. Systematic diagnostic approach to primary acute pericardial disease.//Cardiol. Clin. 1990. Vol. 8, N 4. P. 609-620.Soler-Soler J., Permanyer-Miralda G., Sagrista-Sauleda J.A. Systematic diagnostic approach to primary acute pericardial disease.//Cardiol. Clin. 1990. Vol. 8, N 4. P. 609-620.Гогин Е.Е. Новые возможности и задачи в дифференциальной диагностике перикардитов.//Клин. медицина. 1983. № 11. С. 24-30.Гогин Е.Е. Новые возможности и задачи в дифференциальной диагностике перикардитов.//Клин. медицина. 1983. № 11. С. 24-30.Shabetai R. Acute pericarditis.//Cardiol. Clin. 1990. Vol. 8, N 4. P. 639-644.Shabetai R. Acute pericarditis.//Cardiol. Clin. 1990. Vol. 8, N 4. P. 639-644.Yoneda S., Ohte N., Samoto Т., Kobayashi Т., et al. Two cases of viral myocarditis and one case of viral pericarditis.//Jap. Circul. J. 1982. Vol. 46. P. 1222-1226.Yoneda S., Ohte N., Samoto Т., Kobayashi Т., et al. Two cases of viral myocarditis and one case of viral pericarditis.//Jap. Circul. J. 1982. Vol. 46. P. 1222-1226.B. Maisch, A.D. Ristic, S. Pankuweit. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone.//Eur. Heart J. 2002. Vol. 23. P. 1503-1508.B. Maisch, A.D. Ristic, S. Pankuweit. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone.//Eur. Heart J. 2002. Vol. 23. P. 1503-1508.Fujioka S., Koide H., Kitaura Y., et al. Molecular detection and differentiation of enteroviruses in endomyocardial biopsies and pericardial effusions from dilated cardiomyopathy and myocarditis.//Am. Heart J. 1996. Vol. 131. P. 760-765.Fujioka S., Koide H., Kitaura Y., et al. Molecular detection and differentiation of enteroviruses in endomyocardial biopsies and pericardial effusions from dilated cardiomyopathy and myocarditis.//Am. Heart J. 1996. Vol. 131. P. 760-765.Гогин Е.Е. Перикардиты.//Кардиология. 1991. № 2. С. 80-86.Гогин Е.Е. Перикардиты.//Кардиология. 1991. № 2. С. 80-86.Chia J.K.S., Jackson В. Myopericarditis due to parvovirus B19 in an adult.//Clin. Infect. Dis. 1996. Vol. 23. P. 200-201.Chia J.K.S., Jackson В. Myopericarditis due to parvovirus B19 in an adult.//Clin. Infect. Dis. 1996. Vol. 23. P. 200-201.Orth Т., et al. Human parvovirus В19 infection associated with severe acute perimyocarditis in a 34-year-old man [letter].//Eur. Heart J. 1997. Vol. 18, N 3. P524-525.Orth Т., et al. Human parvovirus В19 infection associated with severe acute perimyocarditis in a 34-year-old man [letter].//Eur. Heart J. 1997. Vol. 18, N 3. P524-525.Schonian U., Paul R., Gemsa D., Maisch B. Soluble interleukin-2 receptor, interleukin-6 and tumoral necrosis factor-alfa in inflammatory pericardial effusions. XVII Congr. of the Europ. Society of Card.//Eur. Heart J. 1995. Vol. 16. (abstr. Suppl.). ref. № 1711.Schonian U., Paul R., Gemsa D., Maisch B. Soluble interleukin-2 receptor, interleukin-6 and tumoral necrosis factor-alfa in inflammatory pericardial effusions. XVII Congr. of the Europ. Society of Card.//Eur. Heart J. 1995. Vol. 16. (abstr. Suppl.). ref. № 1711.D.H. Spodick. Intrapericardial treatment of persistent autoreactive pericarditis/myopericarditis and pericardial effusion.//Eur. Heart J. 2002. Vol. 23. P. 1481-1482.D.H. Spodick. Intrapericardial treatment of persistent autoreactive pericarditis/myopericarditis and pericardial effusion.//Eur. Heart J. 2002. Vol. 23. P. 1481-1482.Бойцов С.А., Дерюгин М.В. Современные возможности диагностики неревматических миокардитов.//Consilium Medicum. 2002. Vol. 4. P. 117-124.Бойцов С.А., Дерюгин М.В. Современные возможности диагностики неревматических миокардитов.//Consilium Medicum. 2002. Vol. 4. P. 117-124.Marcolongo R., Russo R., Laveder F., Noventa F., Agostini С. Immunosuppressive therapy prevents recurrent pericarditis.//J. Am. Coll. Cardiol. 1995. Vol. 26, N 5. P. 1276-1279.Marcolongo R., Russo R., Laveder F., Noventa F., Agostini С. Immunosuppressive therapy prevents recurrent pericarditis.//J. Am. Coll. Cardiol. 1995. Vol. 26, N 5. P. 1276-1279.Гуревич М.А., Мравян С.Р., Григорьева Н.М. Особенности клиники, диагностики и лечения миоперикардитов.//Клин. медицина. 1999. № 7. С. 33-36.Гуревич М.А., Мравян С.Р., Григорьева Н.М. Особенности клиники, диагностики и лечения миоперикардитов.//Клин. медицина. 1999. № 7. С. 33-36.Mason J.W., O'Connell J. B., Herskowitz N.E., et al. A clinical trial of immunosuppressive therapy for myocarditis.//New Engl. J. Med. 1995. Vol. 333. P. 269-275.Mason J.W., O'Connell J. B., Herskowitz N.E., et al. A clinical trial of immunosuppressive therapy for myocarditis.//New Engl. J. Med. 1995. Vol. 333. P. 269-275.Hahn E.A., Hartz V.L., Moon Т.Е., et al. The Myocarditis Treatment Trial: Design, methods and patient enrolment.//Eur. Heart J. 1995. Vol. 16. P. 162-167.Hahn E.A., Hartz V.L., Moon Т.Е., et al. The Myocarditis Treatment Trial: Design, methods and patient enrolment.//Eur. Heart J. 1995. Vol. 16. P. 162-167.Maisch В., Schonian U., Hengstenberg C., et al. Immunosuppressive treatment in autoreactive myocarditis -results from a controlled trial.//Postgrad. Med. J. 1994. Vol. 70 (Suppl. 1). S29-34.Maisch В., Schonian U., Hengstenberg C., et al. Immunosuppressive treatment in autoreactive myocarditis -results from a controlled trial.//Postgrad. Med. J. 1994. Vol. 70 (Suppl. 1). S29-34.Grag A., Shiau J., Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis.//Ann. Intern. Med. 1998. Vol. 129. P. 317-322.Grag A., Shiau J., Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis.//Ann. Intern. Med. 1998. Vol. 129. P. 317-322.Frustaci A., Pieroni M., Chimenti C. Immunosuppressive therapy in inflammatory cardiomyopathy.//Eur. Heart J. 2002. Vol. 4 (Suppl. l). P. 169-173.Frustaci A., Pieroni M., Chimenti C. Immunosuppressive therapy in inflammatory cardiomyopathy.//Eur. Heart J. 2002. Vol. 4 (Suppl. l). P. 169-173.Kuhl U., Pauschinger M., Noutsias M., et al. Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy.//Eur. Heart J. 2002. Vol. 4 (Suppl. l). P. 173-180.Kuhl U., Pauschinger M., Noutsias M., et al. Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy.//Eur. Heart J. 2002. Vol. 4 (Suppl. l). P. 173-180.Miric M., Vasiljevic J., Bojic M., et al. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.//Heart. 1996. Vol. 75. P. 596-601.Miric M., Vasiljevic J., Bojic M., et al. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.//Heart. 1996. Vol. 75. P. 596-601.Camargo P.R., Snitcowsky R., da Luz P.L., et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis.//Pediatric Cardiol. 1995. Vol. 16. P. 61-8.Camargo P.R., Snitcowsky R., da Luz P.L., et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis.//Pediatric Cardiol. 1995. Vol. 16. P. 61-8.Schmaltz A.A., Demel K.P., Kallenberg R., et al. Immunosuppressive therapy of chronic myocarditis in children: Three cases and the design of a randomized prospective trial of therapy.//Pediatric Cardiol. 1998. Vol. 19. P. 235-239.Schmaltz A.A., Demel K.P., Kallenberg R., et al. Immunosuppressive therapy of chronic myocarditis in children: Three cases and the design of a randomized prospective trial of therapy.//Pediatric Cardiol. 1998. Vol. 19. P. 235-239.Maisch В., Hufnagel G., Schonian U., Hengstenberg. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID).//Eur. Heart J. 1995. Vol. 16 (Suppl. 0). P. 173-175.Maisch В., Hufnagel G., Schonian U., Hengstenberg. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID).//Eur. Heart J. 1995. Vol. 16 (Suppl. 0). P. 173-175.

The authors declare that there are no conflicts of interest present.